Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 15NETWORK 2NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Carcinoma, Non-Small-Cell Lung 39Lung Neoplasms 38Squamous Cell Carcinoma of Head and Neck 23Uterine Cervical Neoplasms 18Head and Neck Neoplasms 17Unspecified Adult Solid Tumor, Protocol Specific 13Central Nervous System Neoplasms 13Stomach Neoplasms 12Mesothelioma, Malignant 12Neuroblastoma 11Oropharyngeal Neoplasms 10Lymphoma 10Esophageal Neoplasms 10Ovarian Neoplasms 9Carcinoma, Ovarian Epithelial 9Urinary Bladder Neoplasms 8Adenocarcinoma of Lung 8Testicular Neoplasms 7Mouth Neoplasms 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Laryngeal Neoplasms 7Testicular Germ Cell Tumor 6Lymphoma, Large-Cell, Immunoblastic 6Carcinoma 6Astrocytoma 6Teratoma 5Small Cell Lung Carcinoma 5Peritoneal Neoplasms 5Oligodendroglioma 5

Interventions

Dexamethasone 33Cyclophosphamide 28Melphalan 26Specimen Handling 24Biopsy 24Bortezomib 23Magnetic Resonance Spectroscopy 17Calcium Dobesilate 17fludarabine phosphate 15Lenalidomide 15Filgrastim 15Vincristine 12Prednisone 12Peripheral Blood Stem Cell Transplantation 12sargramostim 9dexamethasone acetate 9dexamethasone 21-phosphate 9carfilzomib 9auricularum 9Doxorubicin 9fludarabine 8Thalidomide 8Interferon-alpha 7Cyclosporine 7Busulfan 7trametinib 6Rituximab 6Etoposide 6ixazomib 5Sirolimus 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Multiple Myeloma × Cisplatin × Clear all
NCT00004903 2014-01-06

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

National Cancer Institute (NCI)

Phase 2 Unknown
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡